Aaron S. Mansfield

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 7%percentile

0.109Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Lung Cancer(2023)10.1016/j.lungcan.2023.107423

Top 72%

0.109DataRank

Top 72%1 citations

Chih–Yuan Hsu, Jennifer G. Whisenant, Melina E. Marmarelis, Carolyn J. Presley, Karen L. Reckamp +24 more

Papers

Driven by 29 papers — median percentile 28. Top paper: “First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743”.

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743

Annals of Oncology(2022)10.1016/j.annonc.2022.01.074

N/A

5.7DataRank · unranked

265 citations

Arnaud Scherpereel, Robin Cornelissen, Youssef Oulkhouir, Laurent Greillier, Kaplan Ma +15 more

Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study

The Lancet Diabetes & Endocrinology(2021)10.1016/s2213-8587(21)00120-0

N/A

5.1DataRank · unranked

354 citations

Mimi I. Hu, Lori J. Wirth, Martin Schüler, Aaron S. Mansfield, Giuseppe Curigliano +20 more

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study

The Lancet Oncology(2021)10.1016/s1470-2045(21)00247-3

N/A

5.0DataRank · unranked

445 citations

Giuseppe Curigliano, Dong‐Wan Kim, Ki Hyeong Lee, Benjamin Besse, Christina S. Baik +20 more

Phase II Study of AZD4547 in Patients With Tumors Harboring Aberrations in the FGFR Pathway: Results From the NCI-MATCH Trial (EAY131) Subprotocol W

Journal of Clinical Oncology(2020)10.1200/jco.19.02630

N/A

4.7DataRank · unranked

179 citations

Fangxin Hong, Christos Vaklavas, Heather H. Cheng, Peter S. Hammerman, Edith P. Mitchell +17 more

Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study

Thyroid(2023)10.1089/thy.2023.0363

N/A

1.2DataRank · unranked

55 citations

Mimi I. Hu, Aaron S. Mansfield, Matthew H. Taylor, Martin Schüler, Viola W. Zhu +19 more

NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0539

N/A

0.666DataRank · unranked

84 citations

Whitney Barham, Ying Li, Henan Zhang, Joanina K. Gicobi, Jacob B. Hirdler +24 more

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Lung Cancer(2023)10.1016/j.lungcan.2023.107423

Top 72%

0.109DataRank

Top 72%1 citations

Chih–Yuan Hsu, Jennifer G. Whisenant, Melina E. Marmarelis, Carolyn J. Presley, Karen L. Reckamp +24 more

Safety and efficacy of pralsetinib in RET fusion–positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial

Annals of Oncology(2022)10.1016/j.annonc.2022.08.002

N/A

0DataRank · unranked

181 citations

Giuseppe Curigliano, Michael Thomas, Vivek Subbiah, Christina S. Baik, Daniel S.W. Tan +21 more

Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology

Nature Communications(2022)10.1038/s41467-022-34025-x

N/A

0DataRank · unranked

125 citations

Andrew Srisuwananukorn, Dmitry Karpeyev, Siddhi Ramesh, Sara Kochanny, Brittany Cody +11 more

Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.03.014

N/A

0DataRank · unranked

95 citations

Harvey I. Pass, Güntülü Ak, H. Richard Alexander, Paul Baas, Francine Baumann +47 more

Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial

npj Precision Oncology(2022)10.1038/s41698-022-00256-w

N/A

0DataRank · unranked

43 citations

Zihan Wei, Ranee Mehra, Alice T. Shaw, Christopher H. Lieu, Patrick M. Forde +24 more

Expression, correlation, and prognostic significance of different nicotinic acetylcholine receptors, programed death ligand 1, and dopamine receptor D2 in lung adenocarcinoma

Frontiers in Oncology(2022)10.3389/fonc.2022.959500

N/A

0DataRank · unranked

5 citations

Tabish Hussain, Hao Xie, Shenduo Li, Ping Yang, Aaron S. Mansfield +4 more

The use of artificial intelligence with uncertainty estimation to predict lung cancer relapse from histopathology.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8549

N/A

0DataRank · unranked

1 citations

Sara Kochanny, Annie Zhu, Sagar Rakshit, Radhika Bansal, Melanie C. Bois +6 more

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps8598

N/A

0DataRank · unranked

1 citations

Austin W. Goodrich, Nathan R. Foster, Vinicius Ernani, Patrick M. Forde, Liza C. Villaruz +12 more

Resilient CD8 + T cells maintain a high cytotoxic capacity by balancing ROS via ME1 upregulation

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.25.517988

N/A

0DataRank · unranked

1 citations

Zhiming Mao, Grace DeFranco, Ying Li, Xin Liu, Jacob B. Hirdler +22 more

Neoadjuvant immunotherapy in sarcomatoid mesothelioma (Alliance A082101).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps8602

N/A

0DataRank · unranked

3 citations

Xiaofei F. Wang, Dennis A. Wigle, Colleen Watt, Gregory A. Masters, Kathryn L. Kelley +3 more

Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps8603

N/A

0DataRank · unranked

1 citations

Austin W. Goodrich, Nathan R. Foster, Panos Savvides, Liza C. Villaruz, Patrick M. Forde +12 more

Data from PD-1 Restrains Radiotherapy-Induced Abscopal Effect

(2023)10.1158/2326-6066.c.6548887.v1

N/A

0DataRank · unranked

0 citations

Haidong Dong, Xin Liu, Susan M. Harrington, Christopher J. Krco, Michael P. Grams +5 more

Data from PD-1 Restrains Radiotherapy-Induced Abscopal Effect

(2023)10.1158/2326-6066.c.6548887

N/A

0DataRank · unranked

0 citations

Haidong Dong, Xin Liu, Susan M. Harrington, Christopher J. Krco, Michael P. Grams +5 more

Randomized trial of anetumab ravtansine and pembrolizumab compared to pembrolizumab for mesothelioma

Lung Cancer(2024)10.1016/j.lungcan.2024.107928

N/A

0DataRank · unranked

16 citations

Jun Vivien Yin, Penelope A. Bradbury, David J. Kwiatkowski, Shiven B. Patel, Lyudmila Bazhenova +24 more

Individualized Cell-Free DNA Monitoring With Chromosomal Junctions for Mesothelioma

JTO Clinical and Research Reports(2024)10.1016/j.jtocrr.2024.100692

N/A

0DataRank · unranked

2 citations

Faye R. Harris, Giannoula Karagouga, Amy Schrandt, Jay Mandrekar, Sarah H. Johnson +14 more

Senescent fibroblasts in the tumor stroma rewire lung cancer metabolism and plasticity

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.07.29.605645

N/A

0DataRank · unranked

3 citations

Nabora S. Reyes, Sang‐Ho Woo, Sakshi Goel, Fia Stratton, Chaoyuan Kuang +4 more

Fluorescence based live cell imaging identifies exon 14 skipped hepatocyte growth factor receptor (MET) degraders

RSC Advances(2025)10.1039/d5ra01441g

N/A

0DataRank · unranked

1 citations

Lin Yang, Wan-Hsin Lin, Ryan W. Feathers, Jennifer Ayers-Ringler, Ezequiel J. Tolosa +17 more

Detecting and Filtering Immune-Related Adverse Events Signal Based on Text Mining and Observational Health Data Sciences and Informatics Common Data Model: Framework Development Study

JMIR Medical Informatics(2020)10.2196/17353

N/A

0DataRank · unranked

11 citations

Kathryn J. Ruddy, Aaron S. Mansfield, Nansu Zong, Andrew Wen, Shintaro Tsuji +5 more

A Population-based Study of Immunotherapy-related Toxicities in Lung Cancer

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.04.003

N/A

0DataRank · unranked

42 citations

Lindsey R. Sangaralingham, Henry J. Henk, Nilay D. Shah, Irbaz Bin Riaz, Aaron S. Mansfield +1 more

Maintaining Equipoise With Maintenance Therapy in Mesothelioma

Clinical Lung Cancer(2020)10.1016/j.cllc.2020.07.006

N/A

0DataRank · unranked

0 citations

Aaron S. Mansfield

Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1–Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042

JTO Clinical and Research Reports(2021)10.1016/j.jtocrr.2021.100205

N/A

0DataRank · unranked

84 citations

Roy S. Herbst, Gilberto de Castro, Rina Hui, Nir Peled, Dong‐Wan Kim +12 more

FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations

Digestive Diseases and Sciences(2021)10.1007/s10620-021-07303-9

N/A

0DataRank · unranked

12 citations

Thomas DeLeon, James M. Bogenberger, Rish K. Pai, Heidi Kosiorek, Jun Yin +26 more

Cell-Free Tumor DNA Dominant Clone Allele Frequency (DCAF) Is Associated With Poor Outcomes In Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy

medRxiv(2021)10.1101/2021.11.01.21265773

N/A

0DataRank · unranked

0 citations

Umair Majeed, Jun Yin, Gehan Botrus, Mohamad Bassam Sonbol, Daniel H. Ahn +25 more

Aaron S. Mansfield

Indexed papers

Top data-sharing exemplar

Papers